Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Paul Ausick | Jan 18, 2015 at 8:20 AM EST

Merck Is Top DJIA Stock in 2015

Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year…

Chris Lange | Jan 13, 2015 at 8:55 AM EST

Short Interest in Biotechs Signals Optimism

24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.

Chris Lange | Jan 9, 2015 at 11:00 AM EST

Gilead Continues to Recover from Express Scripts Loss

Gilead Sciences was picked up by Anthem to provide its hepatitis C drug as the primary option for patients.

Chris Lange | Jan 7, 2015 at 2:51 PM EST

Wells Fargo’s Top Biotech Stocks for 2015

ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech…

Lee Jackson | Jan 7, 2015 at 10:35 AM EST

Analyst’s 8 Top Health Care Stocks for 2015

A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have…

Jon C. Ogg | Jan 6, 2015 at 8:30 AM EST

Top Analyst Upgrades and Downgrades: GE, Gilead, Oracle, Under Armour, El Pollo Loco and More

Tuesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include GE, Gilead Sciences, Oracle, Under Armour…

Chris Lange | Dec 29, 2014 at 10:45 AM EST

Is Gilead Already Coming Back Into Favor?

Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the…

Jon C. Ogg | Dec 29, 2014 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Ambarella, Gilead, MarkWest, PNC, Skyworks, RigNet, Sonus and More

Monday's top analyst upgrades, downgrades and initiations include Ambarella, Gilead Sciences, MarkWest Energy Partners, PNC Financial Services, Skyworks Solutions, RigNet…

Chris Lange | Dec 23, 2014 at 12:15 PM EST

Analysts Predict Big Value Trap for Gilead Investors

Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.

Chris Lange | Dec 22, 2014 at 1:20 PM EST

What the AbbVie and Express Script Deal Means for Gilead

AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.

Chris Lange | Dec 10, 2014 at 10:00 AM EST

Are Investors Signaling Optimism in Biotechs Through Short Interest?

The short interest data are out for the November 28 settlement date, and 24/7 Wall St. has reviewed the top…

Jon C. Ogg | Dec 9, 2014 at 8:25 AM EST

Top Analyst Upgrades and Downgrades: Cisco, DreamWorks, Lululemon, Nabors, Schlumberger, Verizon and More

Tuesday's top analyst upgrades and downgrades from 24/7 Wall St. include Cisco Systems, Dreamworks Animation, Lululemon Athletica, Schlumberger and Verizon…

Chris Lange | Nov 26, 2014 at 11:07 AM EST

Mixed Readings For Biotech Short Interest

ThinkstockThe short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of…

Jon C. Ogg | Nov 21, 2014 at 10:20 AM EST

5 Health Care Stocks That Need to Play Serious Catch Up

24/7 Wall St. has identified five of the lowest performing health care stocks over the past month which need to…

Lee Jackson | Nov 15, 2014 at 9:15 AM EST

Insider Selling Surges as Markets Hit Record High

With the markets at or near record highs, the volume of insider selling has reached some of the highest levels…

1 … 33 34 35 36 37 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Merck Is Top DJIA Stock in 2015

Short Interest in Biotechs Signals Optimism

Gilead Continues to Recover from Express Scripts Loss

Wells Fargo’s Top Biotech Stocks for 2015

Analyst’s 8 Top Health Care Stocks for 2015

Top Analyst Upgrades and Downgrades: GE, Gilead, Oracle, Under Armour, El Pollo Loco and More

Is Gilead Already Coming Back Into Favor?

Top Analyst Upgrades and Downgrades: Ambarella, Gilead, MarkWest, PNC, Skyworks, RigNet, Sonus and More

Analysts Predict Big Value Trap for Gilead Investors

What the AbbVie and Express Script Deal Means for Gilead

Are Investors Signaling Optimism in Biotechs Through Short Interest?

Top Analyst Upgrades and Downgrades: Cisco, DreamWorks, Lululemon, Nabors, Schlumberger, Verizon and More

Mixed Readings For Biotech Short Interest

5 Health Care Stocks That Need to Play Serious Catch Up

Insider Selling Surges as Markets Hit Record High

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Gilead Sciences : GILD

All Gilead Sciences Articles

Merck Is Top DJIA Stock in 2015

Short Interest in Biotechs Signals Optimism

Gilead Continues to Recover from Express Scripts Loss

Wells Fargo’s Top Biotech Stocks for 2015

Analyst’s 8 Top Health Care Stocks for 2015

Top Analyst Upgrades and Downgrades: GE, Gilead, Oracle, Under Armour, El Pollo Loco and More

Is Gilead Already Coming Back Into Favor?

Top Analyst Upgrades and Downgrades: Ambarella, Gilead, MarkWest, PNC, Skyworks, RigNet, Sonus and More

Analysts Predict Big Value Trap for Gilead Investors

What the AbbVie and Express Script Deal Means for Gilead

Are Investors Signaling Optimism in Biotechs Through Short Interest?

Top Analyst Upgrades and Downgrades: Cisco, DreamWorks, Lululemon, Nabors, Schlumberger, Verizon and More

Mixed Readings For Biotech Short Interest

5 Health Care Stocks That Need to Play Serious Catch Up

Insider Selling Surges as Markets Hit Record High

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings